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Until proved otherwise, Covid-19 or SARS CoV-
2 infection is a disease of the century that turns the 
world upside down and inside out at 
multidimensional aspects of human life. Since its 
emergence, it has created a lot of confusion and 
uncertainty on its ultrafast speed of spread in the 
temperate climate zone and the bizarre course of 
the disease state. The so far relatively spared 
tropical countries may be explained by the humid 
and hot weather as it was the case for the majority 
of influenza and other human coronaviruses 
pandemics; for which, the less conduciveness of 
the weather for the survival of the SARS CoV-2 
outside the human body may be attributed to.  
In the interest of this editorial, the less 
morbid and less fatal nature of the Covid-19 to 
pregnant women has also opened a lot of 
discussions and countless speculations. This is 
because; while their immunity is weaker than non-
pregnant women, the high resistance of pregnant 
women to Covid-19 is a paradox for many 
investigators.  
What is known for bacterial and other 
viruses is that pregnant women are highly 
vulnerable to respiratory tract infections, partly 
because of the anatomic and physiologic changes, 
and partly because of the maternal immune 
modulation/suppression effect of pregnancy to 
tolerate an allograft fetus (1,2). The T-helper 2 
anti-inflammatory system dominance (elevation of 
IL-4, IL-10, IL-13 and TGF-beta) is a known 
physiologic adaptation to protect the fetus, but 
makes the mother and the fetus at higher risk for 
viral infection and serious complications (3). 
Interestingly, this is not conspicuously observed in 
the case SARS CoV-2 infection. 
Even among coronaviruses, SARS CoV 
and MERS CoV have caused relatively higher 
maternal morbidity and mortality since they were 
recognized as human pathogen in 2002 and 2012, 
respectively. As small-scale studies showed, 
among five SARS CoV infected pregnant women, 
two required mechanical ventilator, one required 
dialysis and one developed convulsion, but all 
recovered from their illness. Another study 
showed that the case fatality rate of SARS CoV 
was 25% and obstetric complications were 
significant (4). Almost comparably, five of 13 
MERS CoV infected pregnant women required 
mechanical ventilator and 3 died (5).  
Unlike SARS CoV and MERS CoV, none 
of 38 pregnant women with Covid-19 infection 
developed severe pneumonia or died of other 
complications, even those with underlying 
morbidity (hypertensive disease in pregnancy, 
gestational diabetes, influenza, hypothyroidism) 
(6). In this study, reported perinatal complications 
were not related to Covid-19. An investigation of 
147 pregnant women (64 confirmed, 82 suspected 
and 1 asymptomatic with COVID-19) by the 
World Health Organization delegates also 
concluded that pregnant women were not at higher 
risk for developing severe disease due to SARS 
CoV-2 infection (7). A recent systematic review of 
108 pregnant women reported that 3 required 
intensive care unit admissions, but there was no 
maternal death (8) 
Further, unlike many viral infections 
(including Zika virus, Ebola virus, Marburg virus, 
Rubella and Cytomegaloviruses), vertical 
transmission was not previously reported from 
SARS CoV, MERS CoV and SARS CoV-2 
infections, even in the presence of obstetric risk 
factors (premature rupture of fetal membranes, 
preeclampsia and vaginal operative deliveries) (6, 
8, 9). Many authors are not yet convinced with the 
recently reported neonates as SARS-CoV-2 
positive following delivery in the range of some 
minutes to 30 hours, to consider them as cases of 
vertical transmission. Similarly, some authors 
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have associated miscarriage, fetal growth 
restriction and preterm delivery with Covid-19 
(10, 11); however, other authors have attributed 
these complications to the underlying obstetric 
disorder (2,4,6) or stated it as warranting further 
investigation (8).  
Although what protects pregnant women 
from developing severe Covid-19 remains being 
enigmatic, the difference in immunologic response 
may partly explain for the difference in the 
severity of maternal illnesses. Patients who 
developed SARS CoV characteristically and 
preferentially showed activation of Th1 immunity, 
thereby resulting in a significant elevation of 
proinflammatory cytokines (IFNγ, IL-1β, IL-6 and 
IL-12) that leads to extensive lungs damage (12). 
That is; the unilateral activation of the Th1 
immunity may give chance for the 
proinflammatory cytokines dominance over the 
anti-inflammatory cytokines and cells, leading to 
what is called “cytokine storm”.  
The immunologic response to women 
with Covid-19, however, is activation of both Th1 
and Th2 immunity (13), which is probably an 
advantage to balance the pro- and anti-
inflammatory mediators. Therefore, the author’s 
assumption for the less vulnerability of pregnant 
women to Covid-19 is the counter effect of the 
already matured and further accentuated Th2 
immunity. The Th2 response is further enhanced 
by the markedly elevated anti-inflammatory and 
immune modulating hormones (like adiponectin, 
prostaglandins, estrogen, progesterone, 
corticosteroid) and other proteins like leukemic 
inhibitory factor, which all are favoring Th2 
immunity activation and Th1 inhibition (14-16).  
As a result, the TH2 response may remain 
dominant even after developing Covid-19, thereby 
reducing the risk of inflammatory reaction, which 
is responsible for severe pneumonia/ARDS and 
systemic damage (17). Advancing pregnancy is 
also characterized by a shift from inflammatory 
macrophages (M1) and natural killer cells (in early 
stage of pregnancy) to anti-inflammatory 
macrophages (M2), which secretes IL-10 and 
TGF-beta, and promotes the TH2 response and 
damaged tissue healing (16,18). Further, what 
makes pregnancy special is the high level of IL-10 
from multiple pregnancy related (placenta and 
decidua) additional cellular sources (trophoblasts, 
uterine natural killer cells, monocytes, and T 
regulatory cells). As a result, it is noted that IL-10 
levels increase markedly starting from the first 
trimester and remain elevated till the end of the 
third trimester (19), which is probably the major 
determinant factor for the less aggressive nature of 
Covid-19 in pregnancy.  
The weak inflammatory response during 
pregnancy (as a result of Th1 suppression) is 
known to worsen influenza, malaria and SLE 
(Th2-type autoimmune disease). To the contrary, 
many of the Th1 and Th17-type autoimmune 
diseases (including multiple sclerosis, rheumatoid 
arthritis, Graves’ disease, the myasthenia gravis) 
undergo a remarkable remission during pregnancy 
and flare up in the postpartum period (14). Such 
phenomena seem as well replicable to Covid-19. 
There is large body of data, which described the 
damage due to Covid-19 is not due to direct effect 
of the virus to the cells; rather, due to the 
immunopathogenic effect of the virus, mimicking 
autoimmune diseases, and usually occurring after 
the second week of infection or after the virus 
shedding is minimal (20). This is despite the fact 
that females are at higher risk of autoimmune 
disease, for which the extra X-chromosome is 
implicated (21). The implication is that pregnant 
women have a cumulative advantage for not to 
have a worsening illness of the Covid-19, like the 
Th1 and Th17-types of autoimmune diseases.   
One may also argue that age is a factor for 
the less morbid and less fatal nature of the Covid-
19 in pregnant women (who usually conceive in 
<40 years of age) as the severity of this virus and 
its cousins (SARS CoV and MERS CoV) were 
associated with increased age (22). No person died 
under the age of 24 years during the 2002-2003 
SARS CoV pandemic. In the general population, 
it is well noted that the severity of the Covid-19 
illness and mortality are positively correlated with 
age. Unlike influenza virus, children and young 
persons are less vulnerable (<1%) to all types of 
the fatal human coronaviruses (OC43, SARS CoV, 
MERS CoV and SARS CoV-2) complicating with 
severe pneumonia and ARDS (23, 24). Inoculation 
of SARS CoV and SARS CoV-2 to experimental 
animals has also shown early detection of the virus 
in the nasal swab in the young and increased lungs 
lesion and prolonged viral shedding in the aged 
animals (22).   
In general, there is a large body of 
observational data that has shown the non-life-
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threatening effect of Covid-19 to pregnant women, 
for which the immune-hormonal physiologic 
changes seem exceptionally protective from the 
SARS CoV-2 fatal injury to the respiratory and 
other organ-systems. Studying in depth the 
hormonal and immunological responses of 
pregnant women to SARS CoV-2 is probably one 
step forward to identify the key factors that switch 
off the disease progress at certain point. In 
particular, the therapeutic or prophylactic role of 
IL-10, which has both anti-inflammatory and 
antifibrotic action in resident lung cells and others 
(25), is an area of interest for research to explore 
its action on SARS CoV-2.   
The current issue of the journal, the third 
regular issue for the year 2020, contains twelve 
original articles, three reviews and a 
correspondence focusing on various topics. The 
correspondence written by one of the eminent 
researchers and clinician details on the effect of the 
current pandemic-COVID-19 on Africa and the 
tropics. We recommend everyone to read it and 
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